MELOXICAM 0.5 mg/mL
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders such as discospondylosis, arthropathy and soft tissue injuries.
SHAKE WELL BEFORE USE
Discard 3 months after initial use when stored below 25° C (air conditioning).
Should be administered orally either mixed with food or directly into the mouth around meal times.
Initial treatment: a single dose of 0.1 mg meloxicam /kg bodyweight on the first day.
Daily maintenance dose: 0.05 mg/kg bodyweight.
Particular care should be given with regard to the accuracy of dosing.
A clinical response is normally seen within 7 days. Where treatment is continued for more than 7 days, cats should be closely monitored for adverse effects. Treatment should be discontinued after 14 days at the latest if no clinical improvement is apparent
Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders such as discospondylosis, arthropathy and soft tissue injuries.
Developed by Mimrox Australia